SCHEMBL8340651

SCHEMBL8340651

C[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CCC3(O)O)[C@H]12

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 5/20 0.82
CYP19A1 P11511 1/20 0.70
ALDH1A1 P00352 2/20 0.64
NR3C1 P04150 3/20 0.52
PGR P06401 2/20 0.52
ADRA1A P35348 2/20 0.52
HTR2B P41595 2/20 0.52
AR P10275 2/20 0.52
LMNA P02545 4/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C19 P33261 2/20 0.50
MAPT P10636 2/20 0.50
BLM P54132 2/20 0.50
NFKB1 P19838 1/20 0.50
HIF1A Q16665 1/20 0.50
ABCB11 O95342 1/20 0.50
ESR1 P03372 1/20 0.50
CHRM2 P08172 1/20 0.50
ABCB1 P08183 1/20 0.50
NR3C2 P08235 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8340653 1.00 SHBG (0.82) SHBGCYP19A1ALDH1A1NR3C1PGR
Bolasterone SCHEMBL4945157 0.90 SHBG (1.00) SHBGCYP19A1ALDH1A1NR3C1PGR
Bolasterone SCHEMBL10904938 0.90 SHBG (1.00) SHBGCYP19A1ALDH1A1NR3C1PGR
Bolasterone SCHEMBL11876760 0.90 SHBG (1.00) SHBGCYP19A1ALDH1A1NR3C1PGR
Calusterone SCHEMBL4509 0.90 SHBG (1.00) SHBGCYP19A1ALDH1A1NR3C1PGR
Bolasterone SCHEMBL145066 0.90 SHBG (1.00) SHBGCYP19A1ALDH1A1NR3C1PGR
Bolasterone SCHEMBL5656551 0.90 SHBG (1.00) SHBGCYP19A1ALDH1A1NR3C1PGR
SCHEMBL5700143 0.86 SHBG (0.76) SHBGCYP19A1ALDH1A1NR3C1PGR
SCHEMBL5700149 0.86 SHBG (0.76) SHBGCYP19A1ALDH1A1NR3C1PGR
SCHEMBL9126706 0.85 SHBG (0.74) SHBGCYP19A1ALDH1A1NR3C1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5990328-A FORMING 4-NITRO-3-KETOSTEROIDS WHICH BY NITRATION OF THE CORRESPONDING 3,5-DIENOLATE, REDUCTION OF 4-NITRO-3-KETOSTEROID FORMS 4-AMINO-3-KETOSTEROID MERRELL PHARMACEUTICALS INC. (US) 1999-11-23 US disclosed
US-5965550-A INHIBITING STEROID C17-20 LYASE BY ADMINISTERING A 4-NITRO STEROID INHIBITORY COMPOUND OF GIVEN FORMULA, SUCH AS 17B-CYCLOPROPYLOXY-4-NITROANDROST-4-EN-3-ONE; INHIBITS FORMATION OF BOTH ANDROGENIC AND ESTROGENIC STEROIDS MERRELL PHARMACEUTICALS INC. (US) 1999-10-12 US disclosed
US-5869475-A Certain 3-ketosteroids used to inhibit steroid 5α-reductase MERRELL PHARMACEUTICALS, INC. (US) 1999-02-09 US disclosed
EP-0758340-B1 PROCESS FOR THE PREPARATION OF 4-AMINO-DELTA 4-3-KETOSTEROIDS VIA 4-NITRO-DELTA 4-3-KETOSTEROIDS MERRELL PHARMA INC (US) 1999-01-07 EP disclosed
US-5750744-A ENZYME INHIBITORS MERRELL PHARMACEUTICALS INC. (US) 1998-05-12 US disclosed
EP-0758340-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-DELTA 4-3-KETOSTEROIDS VIA 4-NITRO-DELTA 4-3-KETOSTEROIDS MERRELL PHARMACEUTICALS INC. (US) 1997-02-19 EP disclosed
WO-1995029932-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-Δ4-3-KETOSTEROIDS VIA 4-NITRO-Δ4-3-KETOSTEROIDS MERRELL PHARMACEUTICALS INC. (US) 1995-11-09 WO disclosed